Lung Cancer Surgery Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Lung Cancer Surgery Market
Lung Cancer Surgery Market: By Type (Thoracotomy, Minimally Invasive Procedures), By End-User (Hospitals, Adult Lung Cancer Surgery Centers, Ambulatory Surgical Centers) & By Region - Forecast(2018 - 2023)
Report Code : HCR 0316
Updated Date: 31 May, 2018  

1. Lung Cancer Surgery Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Lung Cancer Surgery Market– Market Forces
   4.1. Drivers
      4.1.1. Favorable reimbursement scenario in the developed countries favors the market for lung cancer surgery
      4.1.2.  Innovations in diagnosis and alternate treatment therapies hinder the surgery market for lung cancer
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Lung Cancer Surgery Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Lung Cancer Surgery Market, By Type
   6.1. Thoracotomy
   6.2. Minimally Invasive Procedures
      6.2.1. Video-Assisted Thoracoscopic Surgery (Vats)
      6.2.2. Robotic Surgery
   6.3. Others
7. Lung Cancer Surgery Market, By End-User
   7.1. Hospitals
   7.2. Adult Lung Cancer Surgery Centers
   7.3. Ambulatory Surgical Centers
8. Lung Cancer Surgery Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Lung Cancer Surgery – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Siemens Healthcare
   10.2. Richard Wolf Gmbh
   10.3. Olympus Cor
   10.4. Neomend Inc.
   10.5. Ethicon Endo-Surgery Inc.
   10.6. Bsd Medical Corp
   10.7. Accuray Inc.
   10.8. Trokamed Gmbh
   10.9. Karl Storz Gmbh & Co. Kg
   10.10. Teleflex Inc.
   10.11. Scanlan International Inc.
   10.12. Intuitive Surgical Inc.
   10.13. Dimeda Surgical Instruments
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll